TURKISH JOURNAL OF GASTROENTEROLOGY, vol.32, no.8, pp.661-666, 2021 (Peer-Reviewed Journal)
Article / Article
TURKISH JOURNAL OF GASTROENTEROLOGY
Science Citation Index Expanded, Scopus, EMBASE, MEDLINE
Fibrosis, metabolic syndrome, metabolic dysfunction-associated fatty liver disease, SEVERITY, STEATOHEPATITIS, PROGRESSION, OUTCOMES, NAFLD
Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.